TITLE

In vivo cell reprogramming to pluripotency: exploring a novel tool for cell replenishment and tissue regeneration

AUTHOR(S)
de Lázaro, Irene; Kostarelos, Kostas
PUB. DATE
June 2014
SOURCE
Biochemical Society Transactions;Jun2014, Vol. 42 Issue 3, p711
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The potential of cell-replacement strategies for the treatment of disorders in which a particular cell type is damaged or degenerated has prompted the search for the perfect cell source. iPSCs (induced pluripotent stem cells) stand out as very advantageous candidates thanks to their self-renewal capacity and differentiation potential, together with the possibility of generating them from autologous somatic cells with minimally invasive techniques. However, their differentiation into the required cell type, precise delivery and successful engraftment and survival in the host are still challenging. We have proposed the transient reprogramming of somatic cells towards a pluripotent state in their in vivo microenvironment as a means to facilitate the regeneration of the tissue. The initial reports of in vivo reprogramming to pluripotency in the literature are reviewed and the potential clinical applications of this strategy are discussed.
ACCESSION #
110618826

 

Related Articles

  • Cell Reprogramming, IPS Limitations, and Overcoming Strategies in Dental Bioengineering. Ibarretxe, Gaskon; Alvarez, Antonia; Cañavate, Maria-Luz; Hilario, Enrique; Aurrekoetxea, Maitane; Unda, Fernando // Stem Cells International;2012, p1 

    The procurement of induced pluripotent stem cells, or IPS cells, from adult differentiated animal cells has the potential to revolutionize future medicine, where reprogrammed IPS cells may be used to repair disease-affected tissues on demand. The potential of IPS cell technology is tremendous,...

  • Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors. Maza, Itay; Caspi, Inbal; Zviran, Asaf; Chomsky, Elad; Rais, Yoach; Viukov, Sergey; Geula, Shay; Buenrostro, Jason D; Weinberger, Leehee; Krupalnik, Vladislav; Hanna, Suhair; Zerbib, Mirie; Dutton, James R; Greenleaf, William J; Massarwa, Rada; Novershtern, Noa; Hanna, Jacob H // Nature Biotechnology;Jul2015, Vol. 33 Issue 7, p769 

    Somatic cells can be transdifferentiated to other cell types without passing through a pluripotent state by ectopic expression of appropriate transcription factors. Recent reports have proposed an alternative transdifferentiation method in which fibroblasts are directly converted to various...

  • Human induced pluripotent stem cells differentiate into insulin-producing cells able to engraft in vivo. Pellegrini, Silvia; Ungaro, Federica; Mercalli, Alessia; Melzi, Raffaella; Sebastiani, Guido; Dotta, Francesco; Broccoli, Vania; Piemonti, Lorenzo; Sordi, Valeria // Acta Diabetologica;Dec2015, Vol. 52 Issue 6, p1025 

    Aims: New sources of insulin-secreting cells are strongly required for the cure of diabetes. Recent successes in differentiating embryonic stem cells, in combination with the discovery that it is possible to derive human induced pluripotent stem cells (iPSCs) from somatic cells, have raised the...

  • Establishment of Human cell Type-Specific iPS cells with Enhanced Chondrogenic Potential. Guzzo, Rosa; Scanlon, Vanessa; Sanjay, Archana; Xu, Ren-He; Drissi, Hicham // Stem Cell Reviews & Reports;Dec2014, Vol. 10 Issue 6, p820 

    The propensity of induced pluripotent stem (iPS) cells to differentiate into specific lineages may be influenced by a number of factors, including the selection of the somatic cell type used for reprogramming. Herein we report the generation of new iPS cells, which we derived from human...

  • Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells. Kang, Xiangjin; Yu, Qian; Huang, Yuling; Song, Bing; Chen, Yaoyong; Gao, Xingcheng; He, Wenyin; Sun, Xiaofang; Fan, Yong // PLoS ONE;7/1/2015, Vol. 10 Issue 7, p1 

    Human-induced pluripotent stem cells (iPSCs) are derived from differentiated somatic cells using defined factors and provide a renewable source of autologous cells for cell therapy. Many reprogramming methods have been employed to generate human iPSCs, including the use of integrating vectors...

  • In Vitro Modeling of Paraxial Mesodermal Progenitors Derived from Induced Pluripotent Stem Cells. Sakurai, Hidetoshi; Sakaguchi, Yasuko; Shoji, Emi; Nishino, Tokiko; Maki, Izumi; Sakai, Hiroshi; Hanaoka, Kazunori; Kakizuka, Akira; Sehara-Fujisawa, Atsuko // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Induced pluripotent stem (iPS) cells are generated from adult somatic cells by transduction of defined factors. Given their unlimited proliferation and differentiation potential, iPS cells represent promising sources for cell therapy and tools for research and drug discovery. However, systems...

  • Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells. Zuojun Tian; Fuzheng Guo; Biswas, Sangita; Wenbin Deng // International Journal of Molecular Sciences;2016, Vol. 17 Issue 4, p594 

    Great progress has been made regarding the capabilities to modify somatic cell fate ever since the technology for generation of induced pluripotent stem cells (iPSCs) was discovered in 2006. Later, induced neural progenitor cells (iNPCs) were generated from mouse and human cells, bypassing some...

  • The Application of Human iPSCs in Neurological Diseases: From Bench to Bedside. Xie, Nina; Tang, Beisha // Stem Cells International;1/6/2016, p1 

    In principle, induced pluripotent stem cells (iPSCs) are generated from somatic cells by reprogramming and gaining the capacity to self-renew indefinitely as well as the ability to differentiate into cells of different lineages. Human iPSCs have absolute advantages over human embryonic stem...

  • Flk1+ and VE-Cadherin+ Endothelial Cells Derived from iPSCs Recapitulates Vascular Development during Differentiation and Display Similar Angiogenic Potential as ESC-Derived Cells. Kohler, Erin E.; Wary, Kishore K.; Li, Fei; Chatterjee, Ishita; Urao, Norifumi; Toth, Peter T.; Ushio-Fukai, Masuko; Rehman, Jalees; Park, Changwon; Malik, Asrar B. // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Rationale:Induced pluripotent stem (iPS) cells have emerged as a source of potentially unlimited supply of autologous endothelial cells (ECs) for vascularization. However, the regenerative function of these cells relative to adult ECs and ECs derived from embryonic stem (ES) cells is unknown....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics